These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 11051241)
1. Functional evaluation of p53 and PTEN gene mutations in gliomas. Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241 [TBL] [Abstract][Full Text] [Related]
2. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
3. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247 [TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas. Fults D; Pedone C Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623 [TBL] [Abstract][Full Text] [Related]
8. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308 [TBL] [Abstract][Full Text] [Related]
9. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of non-astrocytic gliomas. Tong CY; Ng HK; Pang JC; Hui AB; Ko HC; Lee JC Histopathology; 1999 Apr; 34(4):331-41. PubMed ID: 10231401 [TBL] [Abstract][Full Text] [Related]
11. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844 [TBL] [Abstract][Full Text] [Related]
12. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672 [TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in pediatric high-grade astrocytomas. Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506 [TBL] [Abstract][Full Text] [Related]
14. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related]
15. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
17. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients. Zainuddin N; Jaafar H; Isa MN; Abdullah JM Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood. Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345 [TBL] [Abstract][Full Text] [Related]
19. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660 [TBL] [Abstract][Full Text] [Related]
20. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas. Jin W; Xu X; Yang T; Hua Z Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]